Seaport Therapeutics, Inc. (SPTX) stock
SPTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 2, 2026
$18.31+0.14 (+0.77%)
Close on Nov 18, 2026Market cap $980.14MP/E –Yield –
Earnings
Seaport Therapeutics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
–
Not yet scheduled
Revenue, Q3 FY2026
–
EPS, Q3 FY2026
-$0.49
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of Seaport Therapeutics's earnings releases, newest first
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Seaport Therapeutics has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Seaport Therapeutics puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Seaport Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
See a number that looks wrong?